Healthcare and Life Science
PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes
Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Amadeus Capital and Astellas Venture Manageme...
NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman
Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind Appointment of Edwin Moses as Chairman to support the leadership team in maximising the value of the technology plat...
HOPE: Cleanroom Solutions facilitating greatness with elite large-scale turnkey construction builds
Guardtech Group’s complex cleanroom facility construction brand celebrating their role as facilitators of groundbreaking Life Science and R&D innovation ...
Meet Cambridge helps to bring international neurotrauma conference to the city
The official bureau for conferences and events in Cambridge and the surrounding area is seeing the culmination of five years’ preparation as partner to the organising committee for one of the world’s largest medical conferences in its field. ...
Newcells Biotech launches Lung Ciliary Beat Frequency assay to enhance safety and efficacy profiling in preclinical drug development
Application of new CiliaBeat software to provide reliable and predictive data on the impact of drugs on cilia function Assay leverages Newcells’ complex lung small airway in vitro model to enable highly sensitive assessment of drug efficacy and chemical safety as part of expanded se...
Overcoming obstacles in medical device innovation
Co-authored by Samantha Shelley, SQMS
Unlocking opportunities in China's thriving Life Sciences market
As the second-largest healthcare market in the world, China is on an extraordinary trajectory of growth, with its life sciences sector expected to triple in size by 2030. This is an exciting time for UK life science companies looking to expand their horizons. Excellence First Enterprise...
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications Dublin, Ireland, and Cheshire, UK: ERS Genomics Limited, the CRISPR licensing Company, and Medicines Discovery Catapult, an independent, not...
From farms to factories: patient journey to Pulmonary Fibrosis
Rosemary’s health journey has been anything but straightforward. After enduring three years of painful breathing tests with countless visits to her GP and specialist consultants, she was finally given a diagnosis 12 months later—a name that escaped her when her granddaughter asked. Havi...
Sapio Sciences advances the world's first AI-powered lab assistant
Sapio ELaiN couples AI and natural language processing to deliver the future interface for scientists and lab operations Baltimore, MD, 03 September 2024 – Sapio Sciences, the science-aware™ lab informatics platform, announces significant enhancements to Sapio ELaiN, the pioneeri...